Overview

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
To study the pharmacokinetics and safety of naproxcinod in patients with impaired renal function
Phase:
Phase 1
Details
Lead Sponsor:
NicOx
Treatments:
Naproxen
Naproxen-n-butyl nitrate